Free Trial

Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume

Windtree Therapeutics logo
$1.17 +0.04 (+3.54%)
As of 04/30/2025 04:00 PM Eastern

Windtree Therapeutics Short Interest Data

Windtree Therapeutics (WINT) has a short interest of 66,500 shares, representing 8.89% of the float (the number of shares available for trading by the public). This marks a -76.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 734,417 shares to cover all short positions.

Current Short Interest
66,500 shares
Previous Short Interest
279,300 shares
Change Vs. Previous Month
-76.19%
Dollar Volume Sold Short
$78,470.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
3,652,000 shares
Float Size
748,400 shares
Short Percent of Float
8.89%
Today's Trading Volume
101,791 shares
Average Trading Volume
734,417 shares
Today's Volume Vs. Average
14%
Short Selling Windtree Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

WINT Short Interest Over Time

WINT Days to Cover Over Time

WINT Percentage of Float Shorted Over Time

Windtree Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202566,500 shares $78,470.00 -76.2%8.9%0 $1.18
3/31/2025279,300 shares $351,918.00 +466.5%37.3%0.1 $1.26
3/15/202549,300 shares $101,065.00 -40.6%6.6%0 $2.05
2/28/202583,000 shares $263,940.00 +44.9%11.1%0.3 $3.18
2/15/202557,300 shares $393,651.00 -67.1%7.7%0.4 $6.87
1/31/2025174,100 shares $22,737.46 -80.9%1.6%0 $0.13
1/15/2025909,000 shares $220,887.00 +72.4%8.3%0.3 $0.24
12/31/2024527,200 shares $184,150.96 +6.1%5.9%0.2 $0.35
12/15/2024497,000 shares $175,639.80 +228.5%5.6%0.3 $0.35
11/30/2024151,300 shares $80,264.65 +389.6%1.7%0.1 $0.53
11/15/202430,900 shares $14,680.59 -84.2%0.4%0 $0.48
10/31/2024195,700 shares $137,655.38 +301.9%2.4%0.1 $0.70
10/15/202448,700 shares $32,142.00 -50.7%1.4%0 $0.66
9/30/202498,700 shares $235,893.00 +174.9%2.8%0.1 $2.39
9/15/202435,900 shares $113,803.00 -65.9%2.6%0 $3.17
8/31/2024105,400 shares $854,794.00 -6.8%23.9%0.1 $8.11
8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14
7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12
7/15/202447,100 shares $174,270.00 -17.5%10.7%1.5 $3.70
6/30/202457,100 shares $183,291.00 +21.2%12.9%1.8 $3.21
6/15/202447,100 shares $146,010.00 +20.8%10.7%1.7 $3.10
5/31/202439,000 shares $138,060.00 +89.3%9.1%1.6 $3.54
5/15/202420,600 shares $94,784.72 +62.2%4.8%0.8 $4.60
4/30/202412,700 shares $63,881.00 +388.5%3.0%0.6 $5.03
4/15/20242,600 shares $19,656.00 -93.5%N/A0.2 $7.56
3/31/202439,700 shares $14,053.80 +30.2%0.5%0.2 $0.35
3/15/202430,500 shares $10,370.00 -47.8%0.4%0.1 $0.34
2/29/202458,400 shares $21,024.00 -42.2%0.8%0.2 $0.36
2/15/2024101,100 shares $36,092.70 -56.0%1.9%0.3 $0.36
1/31/2024229,600 shares $96,500.88 +353.8%5.3%0.8 $0.42
1/15/202450,600 shares $28,953.32 +25.6%1.0%0.2 $0.57
12/31/202340,300 shares $28,975.70 +108.8%N/A0.3 $0.72
12/15/202319,300 shares $14,089.00 -55.5%0.5%0.2 $0.73
11/30/202343,400 shares $50,344.00 -13.4%1.1%0.4 $1.16
11/15/202350,100 shares $46,081.98 -22.5%1.2%0.5 $0.92
10/31/202364,600 shares $67,830.00 -65.8%1.5%0.5 $1.05
10/15/2023188,900 shares $236,125.00 +540.3%4.3%1.5 $1.25
9/30/202329,500 shares $27,983.70 +81.0%0.7%0.2 $0.95
9/15/202316,300 shares $18,745.00 +27.3%0.4%0.1 $1.15
8/31/202312,800 shares $14,095.36 -75.8%2.0%0.1 $1.10
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
8/15/202352,800 shares $85,536.00 +294.0%7.9%0.2 $1.62
7/31/202313,400 shares $18,626.00 +162.8%2.0%0 $1.39
7/15/20235,100 shares $6,834.00 -42.1%N/A0 $1.34
6/30/20238,800 shares $11,000.00 -90.5%N/A0 $1.25
6/15/202392,500 shares $142,450.00 -2.9%N/A0.1 $1.54
5/31/202395,300 shares $121,984.00 -51.2%N/A0.1 $1.28
5/15/2023195,100 shares $290,699.00 +64.4%N/A0.2 $1.49
4/30/2023118,700 shares $194,668.00 +136.9%68.7%0.1 $1.64
4/15/202350,100 shares $219,438.00 +87.6%8.5%0.1 $4.38
3/31/202326,700 shares $133,233.00 -2.9%4.7%0.2 $4.99
3/15/202327,500 shares $132,550.00 -53.0%4.9%0.3 $4.82
2/28/202358,500 shares $367,380.00 +604.8%10.3%0.6 $6.28
2/15/20238,300 shares $1,232.55 -98.9%N/A0.1 $0.15
1/31/2023754,800 shares $120,768.00 +16.1%N/A1.4 $0.16
1/15/2023650,300 shares $143,033.49 -28.2%N/A1.3 $0.22
12/30/2022905,900 shares $154,003.00 -28.7%N/A2 $0.17
12/15/20221,270,000 shares $226,060.00 +4.1%N/A1.4 $0.18
11/30/20221,220,000 shares $234,850.00 -3.2%N/A1.3 $0.19
11/15/20221,260,000 shares $110,250.00 -9.4%5.3%1.2 $0.09
10/31/20221,390,000 shares $238,385.00 -10.9%7.4%0.7 $0.17
10/15/20221,560,000 shares $379,704.00 +26.8%8.3%0.8 $0.24
9/30/20221,230,000 shares $369,123.00 +44.6%6.5%0.7 $0.30
9/15/2022850,900 shares $314,662.82 -8.3%4.5%0.6 $0.37
8/31/2022928,000 shares $365,632.00 +21.9%5.1%0.7 $0.39
8/15/2022761,500 shares $288,608.50 +0.0%4.2%0.6 $0.38
7/31/2022761,200 shares $299,913.56 -19.9%4.3%3.1 $0.39
7/15/2022950,700 shares $384,558.15 +6.8%5.4%3.4 $0.40
6/30/2022890,200 shares $371,213.40 +3.6%5.1%1.1 $0.42
6/15/2022858,900 shares $365,032.50 -7.5%4.9%1.1 $0.43
5/31/2022928,500 shares $452,179.50 +18.9%5.4%1.2 $0.49
5/15/2022781,200 shares $429,660.00 -12.1%4.5%1.1 $0.55
4/30/2022888,700 shares $657,282.52 +104.6%5.3%1.3 $0.74
4/15/2022434,400 shares $462,679.44 -0.5%2.6%0.6 $1.07
3/31/2022436,400 shares $497,496.00 -9.1%2.6%3.9 $1.14
3/15/2022480,100 shares $458,495.50 +10.4%2.9%3.4 $0.96
2/28/2022434,800 shares $465,236.00 -21.0%2.6%3.1 $1.07
2/15/2022550,600 shares $578,130.00 +60.9%3.3%3.4 $1.05
1/31/2022342,200 shares $386,686.00 -30.6%2.0%1.9 $1.13
1/15/2022493,000 shares $734,570.00 +3.1%2.9%2.5 $1.49
12/31/2021478,000 shares $769,580.00 -19.7%2.8%1.8 $1.61
12/15/2021595,400 shares $940,732.00 -12.9%3.5%1.7 $1.58
11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71
11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72
10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78
10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28
9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06
9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82
8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96
8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82
7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83
6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29
6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28
5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77
5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68
4/30/2021328,000 shares $734,720.00 +35.9%4.7%0.7 $2.24
4/15/2021241,400 shares $555,220.00 +87.1%3.5%0.6 $2.30
3/31/2021129,000 shares $276,060.00 -18.2%3.9%0.4 $2.14
3/15/2021157,600 shares $660,344.00 +81.4%4.6%1 $4.19
2/26/202186,900 shares $438,410.50 +1.6%2.5%1.8 $5.05
2/12/202185,500 shares $469,395.00 -3.9%2.5%3.6 $5.49
1/29/202189,000 shares $501,070.00 -0.8%2.6%5 $5.63
1/15/202189,700 shares $554,346.00 No Change2.6%6.5 $6.18

WINT Short Interest - Frequently Asked Questions

What is Windtree Therapeutics' current short interest?

Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 66,500 shares of WINT short. 8.89% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest.

What is a good short interest percentage for Windtree Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.89% of Windtree Therapeutics' floating shares are currently sold short.

Is Windtree Therapeutics' short interest increasing or decreasing?

Windtree Therapeutics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 66,500 shares, a decline of 76.2% from the previous total of 279,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Windtree Therapeutics' float size?

Windtree Therapeutics currently has issued a total of 3,652,000 shares. Some of Windtree Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Windtree Therapeutics currently has a public float of 748,400 shares.

How does Windtree Therapeutics' short interest compare to its competitors?

8.89% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Galecto, Inc. (5.05%), Palisade Bio, Inc. (1.22%), Kazia Therapeutics Limited (0.27%), Organovo Holdings, Inc. (4.32%), Hepion Pharmaceuticals, Inc. (5.93%), SciSparc Ltd. (4.50%), Virax Biolabs Group Limited (6.39%), Enveric Biosciences, Inc. (7.51%), Synaptogenix, Inc. (0.10%), Revelation Biosciences, Inc. (13.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Windtree Therapeutics stock?

Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Windtree Therapeutics?

A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further.

How often is Windtree Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:WINT) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners